In a recent study led by Dr. Swathi Kaliki from India and SGO’s Prof. Ido Didi Fabian examining retinoblastoma patients across Asian regions, disparities in clinical presentation and treatment outcomes were revealed, with East Asia demonstrating better results compared to South-East Asia. The analysis highlighted challenges such as delayed diagnoses and limited access to advanced treatments, emphasizing the impact of socio-economic factors and resource availability on patient outcomes. The study underscored the need for global collaboration to improve early detection, streamline healthcare systems, and enhance treatment accessibility, ultimately aiming to enhance the prognosis for affected children across the Asian continent.